Phase 3 Systemic Sclerosis Clinical Trials
8 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–8 of 8 trials
Recruiting
Phase 3
Evaluation of Efficacy and Safety of Rituximab and Mycophenolate Mofetil Combination in Patients With Interstitial Lung Disease Related to Systemic Sclerosis
Interstitial Lung Disease With Systemic Sclerosis
University Hospital, Tours102 enrolled1 locationNCT06549231
Recruiting
Phase 3
A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis
Systemic Sclerosis
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company92 enrolled55 locationsNCT07335562
Recruiting
Phase 3
Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease
Interstitial Lung DiseaseSystemic Sclerosis
National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland86 enrolled1 locationNCT06297096
Recruiting
Phase 2Phase 3
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Scleroderma, SystemicSystemic Sclerosis Associated Interstitial Lung Disease
GlaxoSmithKline300 enrolled131 locationsNCT05878717
Recruiting
Phase 3
Topical Cannabidiol Lotion for Pruritus Relief in Scleroderma
Intervention StudySystemic Sclerosis (SSc)Mediciine
Khon Kaen University36 enrolled1 locationNCT07245238
Recruiting
Phase 2Phase 3
Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk
SclerodermaSystemic Sclerosis
University Hospital, Bordeaux90 enrolled10 locationsNCT05098704
Recruiting
Phase 3
Safety and Efficacy of Baricitinib on Skin Tightening in Diffuse Cutaneous Systemic Sclerosis: A Comparative Study With Methotrexate
Diffuse Cutaneous Systemic Sclerosis
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh24 enrolled1 locationNCT06936215
Terminated
Phase 3
Scleroderma-Pulmonary Arterial Hypertension Intervention with Apixaban: The SPHInX Study
Pulmonary Arterial HypertensionSystemic Sclerosis
St Vincent's Hospital Melbourne Pty Ltd170 enrolled14 locationsACTRN12614000418673